Brief: Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate For Treatment Of Metachromatic Leukodystrophy

Q32 Bio

11/08/2022 21:34

Aug 11 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES ANNOUNCES OPTIMIZED, IN VIVO GENE
THERAPY
CANDIDATE FOR TREATMENT OF METACHROMATIC LEUKODYSTROPHY
    * HOMOLOGY MEDICINES INC - HOMOLOGY SEEKS PARTNER TO ADVANCE
DEVELOPMENT CANDIDATE

Source text for Eikon:  ID:nGNX3BFZzZ 
Further company coverage:  FIXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))